New combo therapy aims to shrink head and neck tumors before surgery
Disease control
Recruiting now
This study tests a new approach for people with advanced head and neck cancer that can be surgically removed. Before surgery, patients receive low-dose radiation combined with an immunotherapy drug to shrink the tumor and improve long-term outcomes. The goal is to see if this com…
Phase: PHASE2 • Sponsor: Xiwei XU • Aim: Disease control
Last updated May 17, 2026 11:57 UTC